| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(77)90007-1 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S0140673677900071?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:S0140673677900071?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 69103 |
| P2093 | author name string | H. Lehmann | |
| P. A. Kynoch | |||
| P2860 | cites work | An abnormal hemoglobin in red cells of diabetics | Q28255175 |
| Studies of an unusual hemoglobin in patients with diabetes mellitus | Q28256304 | ||
| Further identification of the nature and linkage of the carbohydrate in hemoglobin A1c | Q33959124 | ||
| Structure of hemoglobin AIc: Nature of the N-terminal β chain blocking group | Q34052959 | ||
| Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus | Q34065358 | ||
| Glycosylation of hemoglobin in vitro: affinity labeling of hemoglobin by glucose-6-phosphate | Q35030408 | ||
| Red cell age-related changes of hemoglobins AIa+b and AIc in normal and diabetic subjects | Q35904624 | ||
| Editorial: Glycosylated hemoglobin and diabetic control | Q67745756 | ||
| Characterization of a previously unidentified hemoglobin fraction | Q70512571 | ||
| Hemoglobin components in patients with diabetes mellitus | Q71748906 | ||
| Studies on the heterogeneity of hemoglobin. XIV. Chromatography of normal and abnormal human hemoglobin types on CM-Sephadex | Q72370295 | ||
| A New N-Terminal Blocking Group Involving a Schiff Base in Hemoglobin AIc* | Q72920596 | ||
| P433 | issue | 8027 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glycosylation | Q898365 |
| P304 | page(s) | 16 | |
| P577 | publication date | 1977-07-01 | |
| 1977-07-02 | |||
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Rapid estimation (2 1/2 hours) of glycosylated haemoglobin for routine purposes | |
| P478 | volume | 2 |
| Q71763792 | A collaborative study of the measurement of glycosylated haemoglobin by several methods in seven laboratories in the United Kingdom |
| Q51655687 | A new colorimetric method for the estimation of glycosylated hemoglobin |
| Q71638960 | A prospective study of the effect of 12 months treatment on serum lipids and apolipoproteins A-I and B in Type 2 (non-insulin-dependent) diabetes |
| Q67341329 | A rapid micro-scale method for the measurement of Haemoglobin A1(a+b+c) |
| Q39502318 | A rapid simplified method for routine measurement of glycosylated haemoglobin |
| Q71793164 | A simple method for routine measurement of glycosylated haemoglobin |
| Q34485656 | Abnormalities in vascular arachidonic acid metabolism in the infant of the diabetic mother. |
| Q71796983 | An automatic method for determination of glycosylated hemoglobins using low-pressure liquid chromatography |
| Q51610525 | An evaluation of long-term glycemic control in non-insulin-dependent diabetes mellitus: the relevance of glycated hemoglobin. |
| Q70219648 | An update on electrophoretic and chromatographic methods in the diagnosis of hemoglobinopathies |
| Q42527359 | B-cell response to a standardized breakfast in end-stage renal failure |
| Q39590604 | Beta Thromboglobulin and Glycosylated Haemoglobin in Diabetes Mellitus |
| Q68933133 | Beta-thromboglobulin and fibrinopeptide A in diabetes mellitus as markers of vascular damage |
| Q70605431 | Blood filterability and hemoglobin-oxygen affinity in diabetic patients with and without retinopathy |
| Q35171344 | Can prepregnancy care of diabetic women reduce the risk of abnormal babies? |
| Q41616384 | Chromatographic and colorimetric detection of glycosylated hemoglobins: A comparative analysis of two different methods |
| Q72635393 | Determination of glycosylated hemoglobins in neonatal blood by isoelectric focusing |
| Q70189195 | Diabetic control in patients treated with once or twice-daily insulin injections, including a comparison of conventional beef and highly purified pork insulins |
| Q70646698 | Diurnal changes in plasma lipoproteins in normal subjects and diabetics |
| Q40705780 | Effect of normal pregnancy upon the glycosylated haemoglobins |
| Q93598473 | Effect of slight plasma glucose decrease on glycosylated hemoglobin in healthy subjects during caloric restriction |
| Q72952927 | Electromyographic study of diabetic and alcoholic polyneuropathic patients treated with gangliosides |
| Q34777371 | Fetal macrosomia and maternal diabetic control in pregnancy |
| Q72571588 | Fibrous disease of the breast, thyroiditis, and cheiroarthropathy in type I diabetes mellitus |
| Q34761699 | Five years' experience of a "prepregnancy" clinic for insulin-dependent diabetics. |
| Q70297810 | Ganglioside treatment in diabetic peripheral neuropathy: A multicenter trial |
| Q40174243 | Glycosylated Haemoglobins: Biochemical Evaluation and Clinical Utility |
| Q34778554 | Glycosylated haemoglobin concentrations in mothers of large babies. |
| Q66908368 | Glycosylated haemoglobin concentrations in newly diagnosed diabetics before and during treatment |
| Q71167245 | Glycosylated haemoglobin in cord blood following normal and diabetic pregnancies |
| Q37184010 | Glycosylated haemoglobin: measurement and clinical use. |
| Q51648382 | Glycosylated hemoglobin (Hb AI) as an indicator of therapy effects in different clinical types of diabetes. |
| Q70353027 | Glycosylated hemoglobin and its temporal relationship to plasma glucose in non-insulin dependent (type 2) diabetes mellitus |
| Q41940457 | Glycosylated hemoglobin concentrations in patients with diabetic neuropathy |
| Q41615347 | Glycosylated hemoglobin in patients with newly discovered juvenile-onset diabetes mellitus in the days immediately following the beginning of insulin treatment |
| Q39802421 | Glycosylated hemoglobins and diabetes mellitus |
| Q33641874 | HLA antigens and other risk factors in the development of retinopathy in type 1 diabetes |
| Q39762097 | Haemoglobin A1 and diabetes mellitus |
| Q40599243 | Haemoglobin A1 in Diabetes Mellitus |
| Q39503298 | Haemoglobin A1, blood glucose, and high-density lipoprotein cholesterol in insulin-requiring diabetics |
| Q72527553 | Haemoglobin Hijiyama: a haemoglobin variant found in connection with glycosylated haemoglobin estimation in a Finnish diabetic boy |
| Q44325966 | Hb Trento: an elongated C-terminal beta chain due to a new frameshift mutation [beta144 (-A)]. |
| Q34055861 | HbA1c standardisation destination--global IFCC Standardisation. How, why, where and when--a tortuous pathway from kit manufacturers, via inter-laboratory lyophilized and whole blood comparisons to designated national comparison schemes. |
| Q71058548 | Hemoglobin A1 in galactosemia, a possible role in monitoring dietary compliance |
| Q66956229 | High-carbohydrate diets and insulin-dependent diabetics |
| Q71570570 | High-density lipoprotein cholesterol and apolipoprotein A-I levels at diagnosis in patients with non-insulin dependent diabetes |
| Q66704465 | Hypothalamic releasing factor for reactive depression |
| Q42349769 | In-vitro venous prostacyclin production, plasma 6-keto-prostaglandin F1 alpha concentrations, and diabetic retinopathy |
| Q39721190 | Increased plasma corticosteroid-binding globulin in insulin-dependent pubertal diabetics: Relationships with other glycoproteins, growth hormone and prolactin |
| Q72428467 | Iron deficiency and glycosylated haemoglobin A |
| Q70230988 | Low density lipoprotein cholesterol: an association with the severity of diabetic retinopathy |
| Q66700632 | Maternal/fetal transmission of HBsAg negative hepatitis |
| Q71097280 | Measurement of glycosylated haemoglobins using affinity chromatography |
| Q72423544 | Micro-column method for HbA1 determination |
| Q51660621 | Modification of glycosylated haemoglobin concentration during artificial endocrine pancreas treatment of diabetics. Evidence for a short-term effect on HbA 1 (a+b+c) levels. |
| Q70999286 | Non-suppressible insulin-like activity during pregnancy in women with diabetes mellitus |
| Q39668159 | Nonenzymatically glycosylated proteins. |
| Q63411938 | Open-loop device Microjet MC 2 improves unstable diabetes, lowers the daily insulin requirement and reduces the excursions of plasma free insulin levels: comparison with a traditional intensive treatment |
| Q42467086 | Pancreatic B-cell response to a test-meal in lean and obese diabetic patients: relation to metabolic control |
| Q72620347 | Plasma beta-thromboglobulin in diabetes mellitus |
| Q42799283 | Platelet-derived growth factor (PDGF) in type 1 diabetes mellitus. |
| Q66704466 | Prostacyclin and thromboxane metabolites in diabetes |
| Q40144848 | Protein glycosylation in diabetes mellitus: a review of laboratory measurements and of their clinical utility |
| Q41442883 | Quantitation of hemoglobin A1c: A rapid, automated precision-chromatography technique |
| Q71242304 | Quantitative determination of hemoglobin A1c by thin-layer isoelectric focusing |
| Q71360389 | Rapid fluctuations in glycosylated haemoglobin concentration as related to acute changes in blood glucose |
| Q40112447 | Recent advances in glycosylated hemoglobin measurements |
| Q66700631 | Routine measurement of glycosylated haemoglobin |
| Q40574987 | The Relationship Between the Control of Diabetes Mellitus and Circulating Glycosylated Haemoglobin A1 |
| Q40259675 | The clinical utility of glycosylated hemoglobin |
| Q47280696 | The relationships between maternal HbA1, maternal size and fetoplacental size in indian pregnancies |
| Q70625154 | [Comparison of various methods for determining glycosylated hemoglobins] |
| Q70734568 | [Routine determination of HB A1 by micro-column technique (author's transl)] |
Search more.